ProShares Ultra Nasdaq Biotechnology BIB
Set alert
117.10 USD -3.47 -2.88%
At close · Nov 2
117.47 +0.37 +0.31%
After hours · Nov 2, 4:00 PM ET
117.08 Day range 121.46
68.29 52-week range 126.22
- YTD
- +46.78%
- 1 year
- +63.73%
- Open
- 121.42
- Prev close
- 120.58
- Mkt cap
- 103.65M
- Vol
- 8.03K
- Avg vol
- 9.81K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 117.08
- High
- 121.46
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 59.52
- 200-d avg
- 59.79
5D chart
Signals (15)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 9:40 AM | 17 hours ago |
| SMA: Bearish | Nov 2, 9:40 AM | 17 hours ago |
| SMA: Bullish | Nov 2, 9:30 AM | 17 hours ago |
| SMA: Bullish | Oct 30, 3:50 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:00 PM | 3 days ago |
| SMA: Bullish | Oct 30, 12:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:05 PM | 3 days ago |
| SMA: Bullish | Oct 30, 10:40 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:30 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:05 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 10:05 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 9:40 AM | 3 days ago |
| RSI: Overbought | Oct 30, 9:35 AM | 3 days ago |
| SMA: Bullish | Oct 30, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:55 AM | 4 days ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 59.52
- 200-day average
- 59.79
About ProShares Ultra Nasdaq Biotechnology
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
News
- Capital Investment Advisors LLC Acquires New Holdings in ProShares Ultra Nasdaq Biotechnology $BIB
- ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Price Cross Below 50 Day Moving Average – What’s Next?
- ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Shares Cross Above 50 Day Moving Average – Here’s Why
- BIB: A Tactical 2 X Leveraged Biotech ETF
- Wall Street's Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
- 3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024
- Equity CEFs/ETFs: Top Picks For 2024 - Part II
- Man in Germany Cured of HIV After Undergoing Stem Cell Transplant, According to Report in Nature Medicine
- The 7 Best ETFs to Buy to Cover 2023's Biggest Investing Opportunities
- The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
Your note
Sign in to keep a note on BIB — it syncs with the Stock Master app.